ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,120 | -72.6% | 14,622 | 0.0% | 0.00% | – |
| Q2 2023 | $7,750 | -98.4% | 14,622 | -93.8% | 0.00% | – |
| Q3 2022 | $481,000 | +108.2% | 235,800 | +29.0% | 0.00% | – |
| Q2 2022 | $231,000 | +755.6% | 182,800 | +2189.9% | 0.00% | – |
| Q1 2021 | $27,000 | -90.4% | 7,983 | -91.3% | 0.00% | – |
| Q4 2020 | $282,000 | +57.5% | 91,542 | +34.1% | 0.00% | – |
| Q3 2020 | $179,000 | -27.2% | 68,263 | -9.5% | 0.00% | – |
| Q2 2020 | $246,000 | +54.7% | 75,467 | +13.0% | 0.00% | – |
| Q1 2020 | $159,000 | -79.2% | 66,800 | -58.7% | 0.00% | – |
| Q4 2019 | $763,000 | +88.4% | 161,869 | +70.7% | 0.00% | – |
| Q3 2019 | $405,000 | -27.3% | 94,849 | -0.7% | 0.00% | – |
| Q2 2019 | $557,000 | -26.0% | 95,518 | -51.2% | 0.00% | – |
| Q1 2019 | $753,000 | +19.3% | 195,783 | -42.0% | 0.00% | – |
| Q4 2018 | $631,000 | +12.9% | 337,413 | +93.4% | 0.00% | – |
| Q3 2018 | $559,000 | +48.3% | 174,507 | +40.1% | 0.00% | – |
| Q2 2018 | $377,000 | -32.2% | 124,533 | -12.1% | 0.00% | – |
| Q1 2018 | $556,000 | -58.9% | 141,600 | -56.7% | 0.00% | -100.0% |
| Q4 2017 | $1,354,000 | -29.6% | 327,200 | +4.5% | 0.00% | 0.0% |
| Q3 2017 | $1,922,000 | -21.1% | 313,200 | -20.0% | 0.00% | 0.0% |
| Q2 2017 | $2,436,000 | -9.8% | 391,600 | -8.1% | 0.00% | 0.0% |
| Q1 2017 | $2,701,000 | +70.2% | 426,000 | +73.9% | 0.00% | 0.0% |
| Q4 2016 | $1,587,000 | +1.5% | 245,000 | -11.7% | 0.00% | 0.0% |
| Q3 2016 | $1,563,000 | +5.4% | 277,600 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $1,483,000 | -23.5% | 270,000 | +3.4% | 0.00% | 0.0% |
| Q1 2016 | $1,938,000 | +1897.9% | 261,195 | +2133.4% | 0.00% | – |
| Q4 2015 | $97,000 | -7.6% | 11,695 | 0.0% | 0.00% | – |
| Q3 2015 | $105,000 | +43.8% | 11,695 | +92.6% | 0.00% | – |
| Q2 2015 | $73,000 | +15.9% | 6,071 | +4.3% | 0.00% | – |
| Q1 2015 | $63,000 | +687.5% | 5,820 | +193.9% | 0.00% | – |
| Q2 2014 | $8,000 | – | 1,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |